A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2007
12/26/2007	CN100356973C Medicine for treating indigestion and process for preparing the same
12/26/2007	CN100356963C Anti-thrombosis blood fat-reducing blood pressure-decreasing oral liquid
12/26/2007	CN100356959C Traditional Chinese medicinal composition for reinforcing body fluid, tonifying spleen, dredging deposit and lowering qi, and prepn. method and application thereof
12/26/2007	CN100356954C Heel pain treating externally applied medicine
12/26/2007	CN100356953C Fat-reducing liver-protecting medicine and preparing method
12/26/2007	CN100356952C Chinese medicinal composition for treating heart failure and oral preparation
12/26/2007	CN100356950C Bitter buccal tablet for clearing and moistening throat
12/26/2007	CN100356946C Cappillary artemisia-cape jasmine-rhubarb soft capsule and its prepn process
12/26/2007	CN100356945C Externally used medicine for treating skin carcinoma and its preparing process
12/26/2007	CN100356944C Medicine for relieving-cough and asthma
12/26/2007	CN100356942C Cassia twig-tuckahoe soft capsule and its prepn
12/26/2007	CN100356941C External ointment for curing scald and burn
12/26/2007	CN100356940C Method for preparing piper laetispicum extract, extract and its use
12/26/2007	CN100356939C Medicine for treating osteoporosis and its production method
12/26/2007	CN100356936C Medicine oil for relaxing joints and its prepn
12/26/2007	CN100356934C Health-care food with spot-removing function
12/26/2007	CN100356933C Blood fat reducing and liver protecting medicine prepared with cassia seed extract
12/26/2007	CN100356932C Use of astragalus root in preparing medicine for dilating blood vessel
12/26/2007	CN100356929C Medicinal composition for auxiliary treatment of asthenia healthy qi and its quality control method
12/26/2007	CN100356928C Use of red yeast in preparing anti-inflammatory medicine
12/26/2007	CN100356926C Ointment medicine for treating bedsore
12/26/2007	CN100356925C Clindamycin palmitate hydrochloride dispersion tablet and its preparation method
12/26/2007	CN100356924C Phenoduopan methanesulphonate medicinal composition and its preparation
12/26/2007	CN100356920C Alkaloid liposome in vinca and production technique
12/26/2007	CN100356919C Hydroxycamptothecin liposome and its preparation
12/26/2007	CN100356918C Enteric-coated quick releasing formulation of tannic acid and total matrine for treating enteritis
12/26/2007	CN100356915C Nanometer preparation of silybin and preparation method thereof
12/26/2007	CN100356914C Method for preparing soybean isoflavone tablet
12/26/2007	CN100356912C Tiopronin freeze-dried prepn. and its preparing method
12/26/2007	CN100356911C Compressed-shaping formulation for hypnosis
12/26/2007	CN100356908C Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
12/26/2007	CN100356907C Controlled release dosage forms using acrylic polymer, and process for making
12/26/2007	CN100356906C Method for preparing hollow minisphere for lung administration
12/26/2007	CN100356905C Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
12/26/2007	CN100356871C Powder of amino acids and method for producing the same
12/26/2007	CA2610439A1 Unit dosage forms of temozolomide
12/25/2007	US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
12/25/2007	US7312196 Formulations for amylin agonist peptides
12/25/2007	US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12/25/2007	US7311928 Topical compositions containing tea tree oil for treatment of viral lesions
12/25/2007	US7311926 mixing chymotrypsin with polysiloxane, then polymerizing to form particle
12/25/2007	US7311925 Applying to surface a pharmacologically acceptable composition comprising isoleucine in a microbial blocking quantity
12/25/2007	US7311924 Compositions and methods for treating cancer
12/25/2007	US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007	US7311908 Pharmaceutical compositions of fibrinolytic agent
12/25/2007	US7311894 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide.
12/25/2007	US7311731 Prevention of myocardial infarction induced ventricular expansion and remodeling
12/25/2007	US7311691 Rapid infusion system
12/21/2007	WO2007147133A1 Stabilized tetracycline compositions
12/21/2007	WO2007147125A2 Tetracycline package formulations
12/21/2007	WO2007147094A2 Novel polymer-nano/microparticle composites
12/21/2007	WO2007146943A2 Nanoparticulate kinase inhibitor formulations
12/21/2007	WO2007146805A2 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
12/21/2007	WO2007146684A1 Ophthalmic compositions comprising a branched, glycerol compound and a cationic antimicrobial
12/21/2007	WO2007146683A2 Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
12/21/2007	WO2007146652A1 Unit dose form of glufosfamide
12/21/2007	WO2007146514A2 System for monitoring of patients
12/21/2007	WO2007146448A1 Pharmaceutical formulations of glp-1 derivatives
12/21/2007	WO2007146426A2 Nanoshells for drug delivery
12/21/2007	WO2007146296A1 Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders
12/21/2007	WO2007146234A2 Solid oral dosage form containing an enhancer
12/21/2007	WO2007146173A2 A method for depletion of caries-causing bacteria in the oral cavity
12/21/2007	WO2007146103A2 Infused sponge delivery system
12/21/2007	WO2007146068A2 Controlled release alfuzosin hydrochloride formulation
12/21/2007	WO2007146006A2 Sustained release oxycodone composition with acrylic polymer and a surfactant
12/21/2007	WO2007146005A2 Sustained release oxycodone composition with acrylic polymer and metal hydroxide
12/21/2007	WO2007145993A2 Modified compositions and methods for enhancing brain function
12/21/2007	WO2007145909A2 Methods and compositions for treating post-myocardial infarction damage
12/21/2007	WO2007145868A1 Treating cystic fibrosis with antibiotics via an aerosol drug
12/21/2007	WO2007145866A1 Treating cystic fibrosis with antibiotics via a swirler delivery
12/21/2007	WO2007145824A2 Self-foaming cement for void filling and/or delivery systems
12/21/2007	WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue
12/21/2007	WO2007145191A1 Coated tablet
12/21/2007	WO2007144902A1 Chewable bilayer tablet formulation
12/21/2007	WO2007144894A1 Hydrocolloid carrier beads with inert filler material
12/21/2007	WO2007144724A1 Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof
12/21/2007	WO2007144604A1 Stable aerosol pharmaceutical formulations
12/21/2007	WO2007144418A1 Oral pharmaceutical composition of a poorly water-soluble active substance
12/21/2007	WO2007144362A1 A suspension comprising benzimidazole carbamate and a polysorbate
12/21/2007	WO2007144323A2 Solid forms containing meloxicam with improved taste and process for their preparation
12/21/2007	WO2007144175A2 Pharmaceutical composition comprising hydrochlorothiazide and telmisartan
12/21/2007	WO2007144143A1 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds
12/21/2007	WO2007144139A2 Pharmaceutical compositions with biological barriers permeation enhancing properties
12/21/2007	WO2007144085A1 Opioid combination wafer
12/21/2007	WO2007144084A2 Type-2 diabetes combination wafer
12/21/2007	WO2007144083A2 Ache-nmda combination wafer
12/21/2007	WO2007144082A2 Combination antihypertensive wafer
12/21/2007	WO2007144081A2 Smoking withdrawal combination wafer
12/21/2007	WO2007144080A2 Combination antidepressants wafer
12/21/2007	WO2007143897A1 A compound with special property, compositon comprising the compound and its preparation and uses
12/21/2007	WO2007143895A1 Supersaturated solution of gemcitabine hydrochloride and prepraration method thereof
12/21/2007	WO2007143851A1 Fermented plant extracts, methods of production and uses
12/21/2007	WO2007124700A3 Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
12/21/2007	WO2007124598A3 Softgel capsules with phytosterols and/or phytostanols and optionlly omega polyunstaurated fatty acids
12/21/2007	WO2007124588A3 Colicinogenic strains of e. coli and use thereof for treatment of k88+-associated diarrhea
12/21/2007	WO2007124250A3 Methods of treating hot flashes with formulations for transdermal or transmucosal application
12/21/2007	WO2007123793A3 Swellable particles for drug delivery
12/21/2007	WO2007122374A3 Colonic drug delivery formulation
12/21/2007	WO2007106468A3 Formulations of sitaxsentan sodium
12/21/2007	WO2007095156A3 Taste masking of aerosolized fluoroquinolones

1 ... 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 ... 2991